What is the recommended protocol for managing hyperglycemia in critically ill patients using the Yale insulin drip protocol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yale Insulin Infusion Protocol for Critically Ill Patients

The Yale insulin infusion protocol is a nurse-managed, continuous IV insulin protocol that targets blood glucose of 120-160 mg/dL (updated from the original 100-140 mg/dL target), using a standardized 1 unit/mL insulin concentration with frequent monitoring every 1-2 hours to minimize hypoglycemia risk. 1

Protocol Preparation and Administration

Insulin Preparation:

  • Prepare continuous insulin infusion at a standardized concentration of 1 unit/mL 2
  • Prime new IV tubing with a 20-mL waste volume before initiating therapy to ensure accurate dosing 2
  • Use human regular insulin for the infusion 2

Blood Glucose Targets and Initiation

When to Start:

  • Initiate insulin infusion when blood glucose ≥150 mg/dL 2, 3
  • Target range: 120-160 mg/dL for the updated Yale protocol 1
  • Absolute upper limit: maintain blood glucose <180 mg/dL at all times 2, 3

Target Achievement:

  • The protocol typically achieves target glucose range within a median of 7 hours 1
  • Once target is reached, mean blood glucose maintained at approximately 156 mg/dL 1
  • Median insulin infusion rate required: 3.5 units/hour 1

Monitoring Requirements

Blood Glucose Monitoring Frequency:

  • Check blood glucose every 1-2 hours during active insulin infusion 2
  • Never use 4-hourly monitoring intervals, as this is associated with hypoglycemia rates >10% 2
  • Use point-of-care glucose meters, though be aware they are acceptable but not optimal due to accuracy limitations in critically ill patients 2

Critical Monitoring Considerations:

  • POC glucose meters may have significant variability and bias compared to laboratory values, particularly in patients with anemia, hypoxia, or on vasopressors 2
  • Arterial blood gas analyzers provide more accurate glucose measurements than bedside meters 2

Hypoglycemia Prevention and Management

Hypoglycemia Risk with Yale Protocol:

  • The updated Yale protocol demonstrates excellent safety with only 0.3% of glucose values <70 mg/dL and 0.02% <40 mg/dL 1
  • This represents a significant improvement over tight glycemic control protocols that showed hypoglycemia rates of 5-18% 2

Hypoglycemia Treatment:

  • For blood glucose <70 mg/dL: immediately reassess and modify insulin regimen 3
  • For symptomatic or severe hypoglycemia: administer IV dextrose (preferred over glucagon due to faster response) 2
  • Use small aliquots of concentrated dextrose to avoid overcorrection and rebound hyperglycemia 2
  • Recheck glucose every 30 minutes to 2 hours during treatment 4

Risk Factors for Hypoglycemia:

  • Nutrition interruption (OR 6.6) 2
  • Diabetes mellitus (OR 2.6) 2
  • Sepsis (OR 2.2) 2
  • Shock (OR 1.8) 2
  • Renal replacement therapy with bicarbonate fluids (OR 14) 2

Nutritional Considerations

Carbohydrate Management:

  • Evaluate amount and timing of carbohydrate intake when calculating insulin requirements 2
  • Include specific instructions for unplanned discontinuation of nutrition or dextrose infusions to prevent hypoglycemia 2
  • Consistent nutritional intake simplifies glycemic management 2
  • Avoid overfeeding, which can worsen hyperglycemia 2

Transition Off IV Insulin

When to Transition:

  • Transition stable ICU patients to protocol-driven basal/bolus subcutaneous insulin before stopping the infusion 2
  • Delay subcutaneous insulin initiation until: 2
    • No planned interruptions of nutrition for procedures
    • Peripheral edema has resolved
    • Patient is off vasopressors
    • Hemodynamically stable

Preferred Subcutaneous Regimen:

  • Use basal-bolus regimen with scheduled basal insulin plus prandial and correction doses for patients with good nutritional intake 3
  • For patients with poor oral intake: use basal-plus correction insulin only 3

Special Population Considerations

Patients Requiring IV Insulin (Not Subcutaneous):

  • Type 1 diabetes mellitus 2
  • Hemodynamically unstable patients 2
  • Patients with changing clinical status (hypothermia, edema, frequent NPO status) 2

Trauma Patients:

  • Target blood glucose <150 mg/dL to reduce infection rates and shorten ICU stays 2

Safety and Quality Measures

Systems-Based Approach:

  • Insulin is a high-alert, high-risk medication requiring standardized protocols 2
  • Accounts for approximately one-third of all major drug-related injurious medication errors 2
  • Use nurse-managed protocols to improve safety and consistency 1

Common Pitfalls to Avoid:

  • Using inaccurate POC glucose meters without understanding their limitations in critically ill patients 2
  • Monitoring glucose less frequently than every 2 hours 2
  • Failing to adjust for nutrition interruptions 2
  • Attempting overly tight control (80-110 mg/dL), which increases hypoglycemia risk without clear mortality benefit 2, 1

References

Research

Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocol.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Blood Glucose Management in Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

D10W Administration for Hypoglycemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.